Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ciraparantag for reversal of anticoagulation induced by different anticoagulant drugs in generally healthy adults as measured primarily by an automated coagulometer device.
Epistemonikos ID: 7b22546bbc155f314f7a9254e674a7d8f3770ad5
First added on: May 07, 2024